helioxanthin has been researched along with lignans in 20 studies
| Studies (helioxanthin) | Trials (helioxanthin) | Recent Studies (post-2010) (helioxanthin) | Studies (lignans) | Trials (lignans) | Recent Studies (post-2010) (lignans) |
|---|---|---|---|---|---|
| 24 | 0 | 10 | 7,024 | 95 | 4,172 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (30.00) | 29.6817 |
| 2010's | 12 (60.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Austin, D; Cheng, YC; Chou, CK; Fu, L; Gullen, E; Kou, YH; Li, Y; Yeh, SF; Yeo, H; Zhu, JL | 1 |
| Cheng, YC; Leung, CH; Li, Y; Ying, CX | 1 |
| Chung, UI; Igawa, K; Itaka, K; Kawaguchi, H; Komiyama, Y; Kugimiya, F; Moro, T; Nakajima, K; Nakamura, K; Ohba, S; Takato, T | 1 |
| Cheng, YC; Leung, CH; Li, Y; Robek, MD; Ying, C | 1 |
| Chou, CK; Hu, CP; Janmanchi, D; Jeng, KS; Kuo, YH; Lin, CH; Tseng, YP; Yeh, SF | 1 |
| Chou, CK; Hsu, HC; Janmanchi, D; Kuo, YH; Lin, CH; Tseng, PC; Yeh, SF | 1 |
| Chung, UI; Komiyama, Y; Nagamune, T; Ohba, S; Shinkai, M; Zhao, J | 1 |
| Huang, RL; Janmanchi, D; Lin, CH; Tseng, YP; Wang, KC; Yeh, SF | 1 |
| Aburatani, H; Chung, UI; Hojo, H; Ihara, S; Komiyama, Y; Nakajima, K; Nishikawa, N; Ohba, S; Takato, T; Yano, F | 1 |
| Jiang, X; Liu, X; Zhan, P | 1 |
| Hour, MJ; Kuo, CS; Kuo, YH; Leung, YM; Lin, SY; Tsou, YH; Wu, PY | 1 |
| Cheng, YC; Tan, S; Ying, C | 1 |
| Chen, TA; Hsieh, JY; Janmanchi, D; Jhuang, HJ; Lin, CH; Tseng, YP; Yeh, SF | 1 |
| Choi, S; Chung, UI; Hojo, H; Maeda, Y; Ohba, S; Shimohata, N; Takato, T; Yamamoto, K | 1 |
| Csupor, D; Fazakas, C; Forgo, P; Hajdu, Z; Haskó, J; Hohmann, J; Jedlinszki, N; Krizbai, IA; Molnár, J; Wilhelm, I | 1 |
| Kao, TT; Lin, CC; Shia, KS | 1 |
| Bau, DT; Hsieh, YL; Hsien, HH; Hsu, HH; Huang, CY; Kuo, WW; Lin, YM; Tu, CC; Velmurugan, BK; Viswanadha, VP | 1 |
| Chikazu, D; Chung, UI; Fujii, Y; Hojo, H; Kawase-Koga, Y; Ohba, S; Sato, M; Yano, F | 1 |
| Chikazu, D; Fujii, Y; Kawase-Koga, Y; Sato, M; Yamakawa, D | 1 |
| Chikazu, D; Fujii, Y; Kanno, Y; Kashiwagi, M; Kawase-Koga, Y; Kitaura, Y; Ohba, S; Sato, M; Yamakawa, D | 1 |
1 review(s) available for helioxanthin and lignans
| Article | Year |
|---|---|
Naturally occurring and synthetic bioactive molecules as novel non-nucleoside HBV inhibitors.
Topics: Alkaloids; Antiviral Agents; Biological Products; Flavanones; Hepatitis B; Heterocyclic Compounds; Humans; Lignans; Terpenes | 2010 |
19 other study(ies) available for helioxanthin and lignans
| Article | Year |
|---|---|
Inhibition of hepatitis B virus gene expression and replication by helioxanthin and its derivative.
Topics: Antiviral Agents; Cell Line, Tumor; Cell Survival; DNA, Viral; Gene Expression Regulation, Viral; Hepatitis B virus; Humans; Lignans; RNA, Viral; Structure-Activity Relationship; Viral Core Proteins; Virus Replication; Xanthines | 2005 |
New targets and inhibitors of HBV replication to combat drug resistance.
Topics: Antiviral Agents; DNA, Viral; Drug Design; Hepatitis B virus; Lignans; Microbial Sensitivity Tests; Nucleic Acid Synthesis Inhibitors; Virus Replication; Xanthines | 2005 |
A novel osteogenic helioxanthin-derivative acts in a BMP-dependent manner.
Topics: 3T3 Cells; Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Cell Differentiation; Dose-Response Relationship, Drug; Drug Combinations; Lignans; Mice; Osteoblasts; Osteogenesis; Transforming Growth Factor beta; Xanthines | 2007 |
Unique antiviral mechanism discovered in anti-hepatitis B virus research with a natural product analogue.
Topics: Antiviral Agents; Benzodioxoles; Cell Death; Cell Line; DNA, Viral; Down-Regulation; Hepatitis B virus; Hepatocyte Nuclear Factors; Humans; Lamivudine; Lignans; Models, Biological; Phthalazines; Promoter Regions, Genetic; Protein Binding; RNA Stability; RNA, Viral; Thermodynamics; Time Factors; Transcription, Genetic; Viral Proteins; Xanthines | 2007 |
The role of helioxanthin in inhibiting human hepatitis B viral replication and gene expression by interfering with the host transcriptional machinery of viral promoters.
Topics: Antiviral Agents; Artificial Gene Fusion; Cell Line; DNA, Viral; Electrophoretic Mobility Shift Assay; Genes, Reporter; Hepatitis B virus; Humans; Lignans; Luciferases; Molecular Structure; Promoter Regions, Genetic; Protein Binding; Transcription, Genetic; Viral Proteins; Virus Replication; Xanthines | 2008 |
Helioxanthin inhibits interleukin-1 beta-induced MIP-1 beta production by reduction of c-jun expression and binding of the c-jun/CREB1 complex to the AP-1/CRE site of the MIP-1 beta promoter in Huh7 cells.
Topics: Cell Line, Tumor; Chemokine CCL4; Cyclic AMP Response Element-Binding Protein; Cyclic AMP Response Element-Binding Protein A; Gene Expression Regulation, Enzymologic; Humans; Interleukin-1beta; JNK Mitogen-Activated Protein Kinases; Lignans; Promoter Regions, Genetic; Protein Binding; Transcription Factor AP-1 | 2008 |
Icariin: a potential osteoinductive compound for bone tissue engineering.
Topics: Animals; Bone Cements; Bone Morphogenetic Protein 2; Bone Regeneration; Calcification, Physiologic; Drug Synergism; Epimedium; Flavonoids; Lignans; Male; Mice; NIH 3T3 Cells; Skull Fractures; Time Factors | 2010 |
Synthesis and the biological evaluation of arylnaphthalene lignans as anti-hepatitis B virus agents.
Topics: Cell Line, Tumor; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lignans; Promoter Regions, Genetic; Structure-Activity Relationship; Viral Core Proteins; Virus Replication | 2010 |
Enhancement of bone formation ex vivo and in vivo by a helioxanthin-derivative.
Topics: 3T3 Cells; Animals; Bone Regeneration; Lignans; Metatarsus; Mice; Organ Culture Techniques; Osteoblasts; Osteogenesis; Pyridines; Skull; Thienopyridines; Thiophenes | 2010 |
Arylnaphthalene lignans from Taiwania cryptomerioides as novel blockers of voltage-gated K+ channels.
Topics: Animals; Benzodioxoles; Cell Line, Tumor; Cupressaceae; Dioxolanes; Lignans; Mice; Neuroblastoma; Plant Extracts; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2010 |
Helioxanthin analogue 8-1 inhibits duck hepatitis B virus replication in cell culture.
Topics: Animals; Antiviral Agents; Benzodioxoles; Cell Line; DNA, Viral; Dose-Response Relationship, Drug; Drug Synergism; Ducks; Hepadnaviridae Infections; Hepatitis B Virus, Duck; Lamivudine; Lignans; Phthalazines; RNA, Viral; Viral Core Proteins; Virus Replication | 2010 |
Synthesis and biological evaluation of helioxanthin analogues.
Topics: Antiviral Agents; DNA, Viral; Gene Expression Regulation, Viral; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Humans; Lignans; RNA, Viral; Structure-Activity Relationship | 2013 |
Bone healing by sterilizable calcium phosphate tetrapods eluting osteogenic molecules.
Topics: Animals; Calcium Phosphates; Cell Line; Femur; Implants, Experimental; Lignans; Male; Mesoderm; Mice; Osteogenesis; Radiography; Rats; Rats, Wistar; Sterilization; Time Factors; Wound Healing | 2013 |
Evaluation of lignans from Heliopsis helianthoides var. scabra for their potential antimetastatic effects in the brain.
Topics: Actin Cytoskeleton; Animals; Asteraceae; Blood-Brain Barrier; Brain; Cell Survival; Endothelial Cells; Humans; Hungary; Lignans; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Plant Roots; Rats; Zonula Occludens-1 Protein | 2014 |
The Total Synthesis of Retrojusticidin B, Justicidin E, and Helioxanthin.
Topics: Catalysis; Cyclization; Dioxolanes; Lignans; Molecular Structure; Naphthalenes | 2015 |
Helioxanthin suppresses the cross talk of COX-2/PGE2 and EGFR/ERK pathway to inhibit Arecoline-induced Oral Cancer Cell (T28) proliferation and blocks tumor growth in xenografted nude mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Arecoline; Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p27; Cyclooxygenase 2; Dinoprostone; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; G2 Phase Cell Cycle Checkpoints; Heterografts; Lignans; Male; MAP Kinase Signaling System; Mice, Nude; Mouth Neoplasms; Signal Transduction; Transcription Factor AP-1 | 2016 |
Bone regeneration by human dental pulp stem cells using a helioxanthin derivative and cell-sheet technology.
Topics: Animals; Bone Regeneration; Cell Differentiation; Cells, Immobilized; Dental Pulp; Heterografts; Humans; Lignans; Mice; Mice, Inbred NOD; Mice, SCID; Osteogenesis; Stem Cell Transplantation; Stem Cells | 2018 |
Bone Regeneration Potential of Human Dental Pulp Stem Cells Derived from Elderly Patients and Osteo-Induced by a Helioxanthin Derivative.
Topics: Adolescent; Adult; Aged; Animals; Bone Regeneration; Cell Differentiation; Core Binding Factor Alpha 1 Subunit; Dental Pulp; Humans; Lignans; Male; Mice; Middle Aged; Osteogenesis; Skull; Stem Cells; Thienopyridines | 2020 |
Effects of Helioxanthin Derivative-Treated Human Dental Pulp Stem Cells on Fracture Healing.
Topics: Animals; Biomarkers; Bone Regeneration; Cell Differentiation; Dental Pulp; Fluorescent Antibody Technique; Fracture Healing; Humans; Immunohistochemistry; Lignans; Mice; Osteogenesis; Stem Cells | 2020 |